Objectives:

•What is the outcome for patients with paratesticular rhabdomyosarcoma?

•Patients with paratesticular rhabdomyosarcoma who were treated with multimodal therapy (radical inguinal orchiectomy, lymph node dissection, chemotherapy and radiation therapy) have a five year overall survival approaching 96%.

•Younger patients (i.e. infants) have a better survival than adolescents.

More advanced disease demonstrate lower survival, with five year overall survival of 25 to 30% in patients with metastatic or high risk tumors (i.e. alveolar histology, positive fusion proteins).